Company Filing History:
Years Active: 2025
Title: Alex T Taguchi: Innovator in Engineered Polypeptides
Introduction
Alex T Taguchi is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. His work has implications for various applications, including antibody screening.
Latest Patents
One of Taguchi's key patents is titled "Engineered CD25 polypeptides and uses thereof." This patent provides engineered polypeptides that incorporate a combination of spatially-associated topological constraints. At least one of these constraints is derived from a CD25 reference target. The patent also outlines methods for selecting these engineered polypeptides and their use as positive and/or negative selection molecules in screening libraries of binding molecules, such as antibodies. Additionally, it includes CD25 antibodies selected using these engineered polypeptides.
Career Highlights
Alex T Taguchi is associated with Ibio Limited, where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in therapeutic development.
Collaborations
Taguchi has collaborated with notable colleagues, including Matthew Paul Greving and Phung Tu Gip. These collaborations have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Alex T Taguchi is a prominent figure in the field of biotechnology, with a focus on engineered polypeptides. His innovative work and collaborations continue to influence the landscape of antibody screening and therapeutic development.